JoVE - Journal of Visualized Experiments
JoVE Visualize
Contact Us
このページは機械翻訳されています。他のページは英語で表示される場合があります。 View in English

USB1は血液形成の発達を調節するmiRNAデデニラゼである.

  • 0Division of Hematology, Department of Medicine, Washington University in St. Louis, St. Louis, MO 63110, USA.
Clinical Neuroscience (new York, N.y.) +

|

2023年3月2日

|

2023年3月2日

PubMedで要約を見る

まとめ

この要約は機械生成です。

ニュートロペニア (PN) によるポイキロダーマでは,RNA外核酵素USB1の変異が血液不全を引き起こす. PAPD5/7を阻害すると,マイクロRNAのレベルを回復させ,新しいPN療法が示唆される.

科学分野

  • 分子生物学
  • 血液学
  • 遺伝学

背景

  • 3'から5'RNA外核酵素USB1の変異は,血液形成不全を引き起こす状態であるニュートロペニア (PN) によるポイキロダーマに関連しています.
  • PNの正確な分子機構は,U6小核RNAの成熟におけるUSB1の既知の役割にもかかわらず,mRNA前スプライシングは影響を受けないため,不明のままである.

研究 の 目的

  • ヒトの血液形成におけるUSB1変異の役割を調査する.
  • PNにおける造血不全に寄与する分子経路を解明する.
  • PNの潜在的治療標的を特定する.

主な方法

  • USB1におけるPN関連変異 (c.531_delA) を有するヒト胚性幹細胞の生成
  • 分析されたマイクロRNA (miRNA) レベルとUSB1変異細胞の3'-エンドアデニル化.
  • USB1変異体におけるPAPD5/7の抑制の影響を評価した.

主要な成果

  • USB1のc.531_delA変異はヒトの血液形成を阻害する.
  • PAPD5 / 7によって追加された3'-endアデニル化尾を除去できないため,ミRNAの調節不全は,USB1変異体における造血不全に寄与する.
  • PAPD5/7の抑制は,USB1変異体における血液形成を回復させる.

結論

  • USB1は重要なmiRNAデデニラゼとして機能する.
  • この研究では,PAPD5/7がUSB1に関連した造血不全の主要な要因であると特定されています.
  • PAPD5/7の阻害は,ニュートロペニアのポイキロダーマの潜在的な治療戦略です.

関連する概念動画

MicroRNAs 01:22

3.1K

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...

Regulation of Hematopoietic Stem Cells 01:01

3.3K

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...

Role of Hematopoietic Growth Factors 01:28

1.5K

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...

Hematopoiesis 01:21

5.5K

The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...

Nonsense-mediated mRNA Decay 02:27

10.7K

The Upf proteins that carry out nonsense-mediated decay (NMD) are found in all eukaryotic organisms, including humans. Each protein has an individual role, but they need to work in collaboration. Upf1 is an ATP-dependent RNA helicase that unwinds the RNA helix. Because Upf1 can unwind any RNA, Upf2 and Upf3 are required to help Upf1 discriminate between nonsense and normal mRNAs.
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...

Multipotency of Hematopoietic Stem Cells 01:19

3.2K

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...